Bicyclo[2.2.2]octane-2,3-diol as an universal linker for the solid-phase synthesis of oligonucleotides
Authors:
- Kazuki YamamotoKYKazuki Yamamoto
- Yasufumi FuchiYFYasufumi Fuchi
- Yuta ItoYIYuta Ito
- Yoshiyuki HariYHYoshiyuki Hari
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Tetrahedron
- Vol. 92
Abstract
No abstract availableKeywords
Funding Information
- Pharmaceutical Society of Japan
This publication has 27 references indexed in Scilit:
- DNA Analogues Modified at the Nonlinking Positions of PhosphorusAccounts of Chemical Research, 2020
- Chemical Synthesis and Biological Application of Modified OligonucleotidesBioconjugate Chemistry, 2020
- Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotidesNature Biotechnology, 2017
- The chemical evolution of oligonucleotide therapies of clinical utilityNature Biotechnology, 2017
- The Medicinal Chemistry of Therapeutic OligonucleotidesJournal of Medicinal Chemistry, 2016
- Oligonucleotide Therapies: The Past and the PresentHuman Gene Therapy, 2015
- Therapeutic targeting of microRNAs: current status and future challengesNature Reviews Drug Discovery, 2014
- RNA therapeutics: beyond RNA interference and antisense oligonucleotidesNature Reviews Drug Discovery, 2012
- An Overview of Sugar‐Modified Oligonucleotides for Antisense TherapeuticsChemistry & Biodiversity, 2011
- Antisense OligonucleotidesAccounts of Chemical Research, 1995